Global /France /Healthcare /Medical Devices /ALBIO

Biosynex S.A.

ALBIO

• EPA: ALBIO • Delayed

0.8000EUR 2%

0.9218 USD

As of 8 June 2026, Biosynex S.A. has a market cap of $17.07M USD, ranking #38193 globally and #454 in France. It ranks #3411 in the Healthcare sector, and #725 in the Medical Devices industry.

Global Rank

38193

Country Rank

454

Sector Rank

3411

Industry Rank

725

Key Stats

Market Cap

$17.07MUSD

14.7M EUR

Enterprise Value

$77.18MUSD

66.98M EUR

Revenue (TTM)

$113.77MUSD

97.95M EUR

EBITDA (TTM)

-$20.67MUSD

-17.94M EUR

Net Income (TTM)

-$82.45MUSD

-70.99M EUR

EBITDA Margin

-18%

Profit Margin

-72%

PS Ratio

0.2

PB Ratio

0.3

Company Profile

Country (HQ)

France

Sector

Healthcare

Industry

Medical Devices

CEO

Larry Abensur open_in_new

Employees

454

Founded

1993

Website

biosynex.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
2%	-9.7%	-2%	-25%	22%	32%	-43%	-89%	-97%

News

Markets

Exchange	Ticker	Price	Quotes
Euronext Paris (EPA) MIC: XPAR PRIMARY	ALBIO Biosynex SA ISIN: FR0011005933 Shares Out.: Shares Outstanding: 18.748M¹ Shares Float: 8.139M² TV: TradingView: EURONEXT: ALBIO SA: Stock Analysis: EPA: ALBIO YF: Yahoo Finance: ALBIO.PA GF: Google Finance: EPA: ALBIO BA: Barron's: ALBIO MS: Morningstar: XPAR: ALBIO	0.8000 EUR	TV: TradingView: EURONEXT: ALBIO SA: Stock Analysis: EPA: ALBIO YF: Yahoo Finance: ALBIO.PA GF: Google Finance: EPA: ALBIO BA: Barron's: ALBIO MS: Morningstar: XPAR: ALBIO
Frankfurt Stock Exchange (FRA) MIC: XFRA	0DL Biosynex SA ISIN: FR0011005933 TV: TradingView: FWB: 0DL SA: Stock Analysis: FRA: 0DL YF: Yahoo Finance: 0DL.F GF: Google Finance: FRA: 0DL BA: Barron's: 0DL MS: Morningstar: XFRA: 0DL	0.7500 EUR	TV: TradingView: FWB: 0DL SA: Stock Analysis: FRA: 0DL YF: Yahoo Finance: 0DL.F GF: Google Finance: FRA: 0DL BA: Barron's: 0DL MS: Morningstar: XFRA: 0DL

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Biosynex S.A.

Biosynex SA designs, manufactures, and distributes rapid diagnostic tests to patients and healthcare professionals in France and internationally. The company develops and markets IVDs in the form of RDTs and TRODs, immunoblot, molecular biology, and POC for screening, diagnosis, and prevention. It also provides thermometers, tensiometers, oximetry, hearing protection products, oral and dental hygiene products, self-tests, thermal pads, inhalation chambers, and thermotherapy products. The company was founded in 1993 and is based in Illkirch-Graffenstaden, France.

Similar Companies

Industry: Medical Devices (France)

Name	Market Cap (USD) diff.	PE	Country
EssilorLuxottica Société anonyme EPA: EL	$97.94B 84.32B EUR 574K%	36.7	France
Sartorius Stedim Biotech S.A. EPA: DIM	$17.72B 15.26B EUR 104K%	56.8	France
bioMérieux S.A. EPA: BIM	$9.56B 8.23B EUR 56K%	20.9	France
Eurobio Scientific Société anonyme EPA: ALERS	$268.97M 231.57M EUR 1K%	47.3	France
Carvolix S.A. EPA: AFME	$196.8M 169.44M EUR 1K%	-	France
Guerbet S.A. EPA: GBT	$174.36M 150.12M EUR 921%	-	France

Industry: Medical Devices (Global)

Name	Market Cap (USD) diff.	PE	Country
Thermo Fisher Scientific Inc. NYSE: TMO	$173.27B 1M%	25.8	United States
Intuitive Surgical, Inc. NASDAQ: ISRG	$160.73B 941K%	56.7	United States
Abbott Laboratories NYSE: ABT	$159.07B 932K%	25.6	United States
Danaher Corp. NYSE: DHR	$126.55B 741K%	34.7	United States
Stryker Corp. NYSE: SYK	$120.69B 707K%	38.3	United States
Medtronic plc NYSE: MDT	$101.9B 597K%	22.2	Ireland

chevron_leftBack